Genetic diversity, transmission dynamics and drug resistance of Mycobacterium tuberculosis in Angola

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Perdigão, João ^a   Clemente, Sofia ^b   Ramos, Jorge ^c   Masakidi, Pedro ^b   Machado, Diana ^c   Silva, Carla ^a   Couto, Isabel ^c   Viveiros, Miguel ^c   Taveira, Nuno ^a,d   Portugal, Isabel ^a  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b Hospital da Divina Provid'ncia   (Angola)

^c INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

^d INSTITUTO SUPERIOR DE CIÊNCIAS DA SAÚDE EGAS MONIZ   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL DNA; TUBERCULOSTATIC AGENT;

ANGOLA; CLASSIFICATION; DRUG EFFECT; EPIDEMIOLOGY; FEMALE; GENETIC VARIATION; GENETICS; GENOTYPING TECHNIQUE; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MOLECULAR EVOLUTION; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PHYLOGENY; TRANSMISSION;

ANGOLA; ANTI-BACTERIAL AGENTS; ANTITUBERCULAR AGENTS; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EVOLUTION, MOLECULAR; FEMALE; GENETIC VARIATION; GENOTYPING TECHNIQUES; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PHYLOGENY; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 85013662122     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep42814     Document Type: Article

References (35)

1. World Health Organization. Global Tuberculosis Report 2015. (World Health Organization, Geneva, 2015
2. Direcção Provincial de Saúde. Relatório Anual de 2013 - Província de Luanda. (Direcção Provincial de Saúde, Governo Provincial de Luanda, República de Angola, Luanda, 2013
3. World Health Organization. Global Tuberculosis Report 2014. (World Health Organization, Geneva, 2014
4. Alland, D., et al. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 330, 1710-1716 (1994
5. Genewein, A., et al. Molecular approach to identifying route of transmission of tuberculosis in the community. Lancet 342, 841-844 (1993
6. Small, P. M., et al. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med 330, 1703-1709 (1994
7. Reed, M. B., et al. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 431, 84-87 (2004
8. Perdigao, J., et al. Unraveling Mycobacterium tuberculosis genomic diversity and evolution in Lisbon, Portugal, a highly drug resistant setting. BMC Genomics 15, 991 (2014
9. Caws, M., et al. The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog 4, e1000034 (2008
10. Coll, F., et al. A robust SNP barcode for typing Mycobacterium tuberculosis complex strains. Nat Commun 5, 4812 (2014
11. Supply, P., et al. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol 44, 4498-4510 (2006
12. Kamerbeek, J., et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 35, 907-914 (1997
13. Supply, P., et al. Variable human minisatellite-like regions in the Mycobacterium tuberculosis genome. Mol Microbiol 36, 762-771 (2000
14. Thierry, D., et al. Characterization of a Mycobacterium tuberculosis insertion sequence, IS6110, and its application in diagnosis. J Clin Microbiol 28, 2668-2673 (1990
15. Weniger, T., Krawczyk, J., Supply, P., Niemann, S. & Harmsen, D. MIRU-VNTRplus: a web tool for polyphasic genotyping of Mycobacterium tuberculosis complex bacteria. Nucleic Acids Res 38, W326-331 (2010
16. Demay, C., et al. SITVITWEB-a publicly available international multimarker database for studying Mycobacterium tuberculosis genetic diversity and molecular epidemiology. Infect Genet Evol 12, 755-766 (2012
17. Van Soolingen, D., de Haas, P. E. W. & Kremer, K. Restriction fragment length polymorphism (RFLP) typing of mycobacteria. Bilthoven, The Netherlands: National Intitute of Public Health and The Environment. 52 (2002
18. Siddiqi, S. & Rüsch-Gerdes, S. MGIT960 Procedure Manual for BACTECTM MGIT 960TM TB System (Also applicable for Manual MGIT). Mycobacteria growth indicator tube (MGIT) culture and drug susceptibility demonstration projects. (Foundation for innovative new diagnostics Ed., 2006
19. Vitol, I., Driscoll, J., Kreiswirth, B., Kurepina, N. & Bennett, K. P. Identifying Mycobacterium tuberculosis complex strain families using spoligotypes. Infect Genet Evol 6, 491-504 (2006
20. Hunter, P. R. & Gaston, M. A. Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity. J Clin Microbiol 26, 2465-2466 (1988
21. Torkaman, M. R., et al. Estimation of Recent Transmission of Mycobacterium Tuberculosis Strains among Iranian and Afghan Immigrants: A Cluster-Based Study. J Clin Diagn Res 8, DC05-08 (2014
22. Munang, M. L., Kariuki, M. & Dedicoat, M. Isoniazid-resistant tuberculosis in Birmingham, United Kingdom, 1999-2010. QJM 108, 19-25 (2015
23. Cox, H., et al. Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance. PLoS Med 3, e384 (2006
24. Pillay, M. & Sturm, A. W. Evolution of the extensively drug-resistant F15/LAM4/KZN strain of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa. Clin Infect Dis 45, 1409-1414 (2007
25. Cohen, K. A., et al. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal. PLoS Med 12, e1001880 (2015
26. Mulenga, C., et al. Low Occurrence of Tuberculosis Drug Resistance among Pulmonary Tuberculosis Patients from an Urban Setting, with a Long-Running DOTS Program in Zambia. Tuberc Res Treat 2010, 938178 (2010
27. He, G. X., et al. Follow-up of patients with multidrug resistant tuberculosis four years after standardized first-line drug treatment. PLoS ONE 5, e10799 (2010
28. Lew, W., Pai, M., Oxlade, O., Martin, D. & Menzies, D. Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis. Ann Intern Med 149, 123-134 (2008
29. Rabna, P., et al. Direct Detection by the Xpert MTB/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West Africa. PLoS ONE 10, e0127536 (2015
30. Mokrousov, I., et al. Latin-American-Mediterranean lineage of Mycobacterium tuberculosis: Human traces across pathogen's phylogeography. Mol Phylogenet Evol 99, 133-143 (2016
31. United Nations High Commissioner for Refugees. 2004 UNHCR Statistical Yearbook. (United Nations High Commissioner for Refugees, Geneva, 2006
32. Bartolo, I., et al. Highly divergent subtypes and new recombinant forms prevail in the HIV/AIDS epidemic in Angola: new insights into the origins of the AIDS pandemic. Infect Genet Evol 9, 672-682 (2009
33. Homolka, S., et al. High genetic diversity among Mycobacterium tuberculosis complex strains from Sierra Leone. BMC Microbiol 8, 103 (2008
34. Mulenga, C., et al. Diversity of Mycobacterium tuberculosis genotypes circulating in Ndola, Zambia. BMC Infect Dis 10, 177 (2010
35. Huynh, G. H., et al. Tuberculosis control strategies to reach the 2035 global targets in China: the role of changing demographics and reactivation disease. BMC Med 13, 88 (2015